P3 Health Partners (NASDAQ:PIII) Shares Up 29.1% – What’s Next?

P3 Health Partners Inc. (NASDAQ:PIII) traded up 29.1% during mid-day trading on Monday . The stock traded as high as $2.96 and last traded at $2.88. 198,749 shares changed hands during trading, an increase of 748% from the average session volume of 23,427 shares. The stock had previously closed at $2.23.

Analyst Upgrades and Downgrades

Several research firms have recently commented on PIII. Weiss Ratings reissued a “sell (e+)” rating on shares of P3 Health Partners in a research report on Thursday, January 22nd. Lake Street Capital dropped their price objective on P3 Health Partners from $20.00 to $12.50 and set a “buy” rating on the stock in a research report on Monday, November 17th. Finally, BTIG Research reiterated a “neutral” rating on shares of P3 Health Partners in a report on Friday, December 12th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $12.50.

P3 Health Partners Stock Down 14.8%

The firm has a market capitalization of $22.35 million, a price-to-earnings ratio of -0.08 and a beta of 0.86. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 2.29. The company’s 50 day moving average price is $2.58 and its 200 day moving average price is $5.64.

Institutional Inflows and Outflows

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC increased its holdings in P3 Health Partners Inc. (NASDAQ:PIII) by 4.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 26,678 shares of the company’s stock after purchasing an additional 1,178 shares during the quarter. Trinity Financial Advisors LLC owned 0.37% of P3 Health Partners worth $239,000 at the end of the most recent reporting period. 7.75% of the stock is owned by institutional investors and hedge funds.

About P3 Health Partners

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.